PRESS DIGEST-Canada - Nov 22

Reuters11-22

PRESS DIGEST-Canada - Nov 22

Nov 22 (Reuters) - The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.

THE GLOBE AND MAIL

** The federal government unveiled its multi billion-dollar plan to alleviate pocketbook pressures for households, dropping the GST on a wide range of products for a two-month period and sending most working Canadians a $250 cheque in April.

** Jazz Pharmaceuticals JAZZ.O, which licensed Zymeworks' ZYME.O lead cancer drug zanidatamab in 2022 for North America, Europe and Japan, said the U.S. FDA had approved use of the tumour-fighting antibody to treat adults with a form of biliary-tract cancer.

**A shareholder advocacy group is calling on Toronto-Dominion Bank TD.TO to launch an independent review of its board of directors after an investigation by U.S. regulators and law enforcement found it guilty of conspiracy to commit money laundering.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485666268?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-22 21:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485666268","market":"us","top_or_hot":-1,"title":"PRESS DIGEST-Canada - Nov 22","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>PRESS DIGEST-Canada - Nov 22</title></head><body><p><span>Nov 22 (Reuters)</span><span> - </span>The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>THE GLOBE AND MAIL</p><p>** The federal government unveiled its multi billion-dollar plan to alleviate pocketbook pressures for households, dropping the GST on a wide range of products for a two-month period and sending most working Canadians a $250 cheque in April.</p><p>** Jazz Pharmaceuticals <span>JAZZ.O</span>, which licensed Zymeworks' <span>ZYME.O</span> lead cancer drug zanidatamab in 2022 for North America, Europe and Japan, said the U.S. FDA had approved use of the tumour-fighting antibody to treat adults with a form of biliary-tract cancer.</p><p>**A shareholder advocacy group is calling on Toronto-Dominion Bank <span>TD.TO</span> to launch an independent review of its board of directors after an investigation by U.S. regulators and law enforcement found it guilty of conspiracy to commit money laundering.</p><p> (Compiled by Bengaluru newsroom)</p><p> ((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST-Canada - Nov 22</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST-Canada - Nov 22\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-22 21:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0Y2:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PRESS DIGEST-Canada - Nov 22Nov 22 (Reuters) - The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.THE ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0Y2:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JAZZ","symbol_name":"爵士制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4N3MT0Y2:1","article_id":"2485666268","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485666268","pubTimestamp":1732281964,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"PRESS DIGEST-Canada - Nov 22Nov 22 (Reuters) - The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.THE GL","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JAZZ":"爵士制药","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4139":"生物科技","ZYME":"ZYMEWORKS INC (US)","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4007":"制药","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"新闻文摘-加拿大-11月22日","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAZZ":0.9,"ZYME":0.9},"content_text":"PRESS DIGEST-Canada - Nov 22Nov 22 (Reuters) - The following are the top stories from a selected Canadian newspaper. Reuters has not verified these stories and does not vouch for their accuracy.THE GLOBE AND MAIL** The federal government unveiled its multi billion-dollar plan to alleviate pocketbook pressures for households, dropping the GST on a wide range of products for a two-month period and sending most working Canadians a $250 cheque in April.** Jazz Pharmaceuticals JAZZ.O, which licensed Zymeworks' ZYME.O lead cancer drug zanidatamab in 2022 for North America, Europe and Japan, said the U.S. FDA had approved use of the tumour-fighting antibody to treat adults with a form of biliary-tract cancer.**A shareholder advocacy group is calling on Toronto-Dominion Bank TD.TO to launch an independent review of its board of directors after an investigation by U.S. regulators and law enforcement found it guilty of conspiracy to commit money laundering. (Compiled by Bengaluru newsroom) ((globalnewsmonitoring@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485666268"}